Start for free
Start for free
EF

ETP Fund

Description

ETP Fund

Investor Profile

ETP Fund has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (33%)
  • Series B (33%)
  • Post Ipo Equity (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Wellness
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ETP Fund frequently co-invest with?

E Squared Capital Management
E Squared Capital Management
North America, New York, United States, New York
Co-Investments: 2
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
IDG Capital
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Syno Capital
Syno Capital
North America, New York, United States, New York
Co-Investments: 2
THE CATALYTIC IMPACT FOUNDATION (CIF)
THE CATALYTIC IMPACT FOUNDATION (CIF)
North America, New York, United States, New York
Co-Investments: 1

Which angels does ETP Fund often collaborate with?

RW
Robert W. Duggan
North America, California, United States, Palo Alto
Shared Deals: 1
FB
Franklin Berger
North America, New York, United States, New York
Shared Deals: 2

What are some of recent deals done by ETP Fund?

Applied Therapeutics

New York, New York, United States

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series BFeb 1, 2019
Amount Raised: $25,000,000
CASI Pharmaceuticals

Rockville, Maryland, United States

CASI focus on building a pipeline through mutually beneficial business development transactions.

BiotechnologyMedicalPharmaceutical
Post Ipo EquityMar 20, 2018
Amount Raised: $50,000,000
Applied Therapeutics

New York, New York, United States

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series AFeb 8, 2017
Amount Raised: $6,067,875
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator